Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent.
Strychnine-sensitive glycine receptors are expressed in many adult forebrain regions, yet the biological function of these receptors outside the spinal cord/brainstem is poorly understood. We have recently shown that rat lateral/basolateral amygdala neurons express strychnine-sensitive glycine-gated currents whose pharmacological and molecular characteristics are consistent with those established for classic ligand-gated chloride channels. The current studies were undertaken to establish the behavioral role, if any, of these strychnine-sensitive glycine receptors. Adult Long-Evans male rats were implanted with guide cannulae targeted at the lateral amygdala and were microinjected with standard artificial cerebrospinal fluid with or without various doses of strychnine or taurine. Anxiety-like behaviors were assessed with the elevated plus maze or the light/dark box. In the elevated plus maze, strychnine decreased closed-arm time and increased open-arm time, suggestive of an anxiolytic effect. Similarly, strychnine produced a modest anxiolytic effect in the light/dark box. Post hoc analysis of 'open-arm' time and 'light-side' time indicated that aCSF-treated animals were distributed into two apparent groups that displayed either high or low amounts of anxiety-like behavior in a given apparatus. Surprisingly, the pharmacological effects of both strychnine and taurine in these assays were dependent upon a given animal's behavioral phenotype. Together, these findings are significant because they suggest that the basal 'emotional state' of the animal could influence the behavioral outcome associated with drug application directly into the lateral/basolateral amygdala. Furthermore, our findings also suggest that compounds acting at amygdala strychnine-sensitive glycine receptors may actively modulate this basal anxiety-like state.
McCool
Brian A
BA
Department of Physiology & Pharmacology, Wake Forest University School of Medicine, Medical Center Building, Winston-Salem, NC 27157, USA. bmccool@wfubmc.edu
Chappell
Ann
A
D000339:Affect / Q000502:physiology; D000679:Amygdala / Q000378:metabolism*; D000704:Analysis of Variance; D000818:Animals; D001007:Anxiety / Q000378:metabolism*; D001362:Avoidance Learning / Q000502:physiology; D018118:Chloride Channels / Q000378:metabolism; D004777:Environment; D005106:Exploratory Behavior / Q000502:physiology; D008297:Male; D008845:Microinjections; D011897:Random Allocation; D051381:Rats; D020318:Rats, Long-Evans; D018009:Receptors, Glycine / Q000187:drug effects / Q000378:metabolism*; D013331:Strychnine / Q000008:administration & dosage / Q000378:metabolism*; D013654:Taurine / Q000008:administration & dosage / Q000378:metabolism*
D018118:Chloride Channels; D018009:Receptors, Glycine; D013654:Taurine; D013331:Strychnine